UCLA study reveals key signs for genetic testing in neurodevelopment disorders

The FDA on Thurs­day grant­ed ac­cel­er­at­ed ap­proval to Am­gen’s bis­pe­cif­ic T cell en­gager tar­latam­ab in small cell lung can­cer, an ag­gres­sive dis­ease that makes up

Alex Den­ner, the in­vestor be­hind the ac­tivist firm Saris­sa Cap­i­tal Man­age­ment, is not win­ning much sup­port for his board up­heaval plans at Irish drug­mak­er Alk­er­mes.

Phar­ma com­pa­nies are ex­press­ing fears that the FDA’s new ad­vanced man­u­fac­tur­ing tech des­ig­na­tion guid­ance could “bur­den” the agency, ac­cord­ing to com­ments re­cent­ly made pub­lic. The